Lv7
4920 积分 2022-01-22 加入
Consensus on standardized later-line systemic therapy for hepatocellular carcinoma
5天前
已完结
Consensus on Standardized Later-Line Systemic Therapy for Hepatocellular Carcinoma
6天前
已完结
A systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis
6天前
已完结
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
6天前
已完结
Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west
6天前
已完结
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis
6天前
已完结
Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
6天前
已完结
Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma
6天前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
6天前
已完结
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1)
6天前
已完结
皖公网安备34019202002308
